Core One Labs Acquires Awakened Biosciences

Core One Labs Acquires Akome Biotech

April 29, 2021

Biotechnology

Core One Labs Inc. (CSE: COOL), a Vancouver-based biotechnology company, entered into a definitive share purchase agreement to acquire all outstanding share capital of Akome Biotech Ltd. Core One will issue 3,500,000 common shares to Akome’s shareholders as consideration; the acquisition expands Core One’s psychedelic-therapeutics R&D capabilities targeting stroke, Alzheimer’s, Parkinson’s and depression.

Core One Labs Acquires New Path Laboratories

December 23, 2021

Food & Beverage

Core One Labs Inc. has completed the acquisition of all outstanding share capital of New Path Laboratories Inc., a British Columbia-based developer and manufacturer of natural health products and functional mushroom dietary supplements. The deal was paid in common shares of Core One and is intended to expand Core One's presence in the functional mushrooms market and add retail distribution channels to generate sales revenue.

Minds + Assembly Acquires Awaken Interactive

October 31, 2024

Marketing & Advertising

Minds + Assembly, a PE-backed healthcare communications and commercialization agency, has acquired Awaken Interactive, a healthcare-focused digital marketing firm specializing in digital media, analytics, technical development and marketing automation. The deal is an add‑on to Minds + Assembly’s platform (backed by Amulet Capital Partners) to expand its analytics and digital capabilities for healthcare clients.

Revive Therapeutics Agrees to Acquire Psilocin Pharma Corp.

February 11, 2020

Pharmaceuticals

Revive Therapeutics Ltd. entered into a letter of intent to acquire all issued and outstanding securities of Psilocin Pharma Corp. for an aggregate purchase price of $2.75 million to be satisfied by issuing 55 million common shares of Revive (deemed $0.05/share). Revive deposited 10 million shares ($500,000) into escrow as a deposit; the closing is subject to due diligence and execution of a definitive share exchange agreement.

Discovery Behavioral Health Acquires Awakenings KC Clinical Neuroscience Institute

December 16, 2021

Healthcare Services

Discovery Behavioral Health has acquired Awakenings KC Clinical Neuroscience Institute in Prairie Village, Kansas. The clinic — led by Dr. Maria Cristina Davila and offering outpatient behavioral-health services including TMS and ketamine infusion therapy — will join Discovery’s nationwide network to expand its outpatient and neuromodulation treatment capabilities in the Kansas City area.

Canopy Biosciences Acquires Core Diagnostics

December 4, 2019

Biotechnology

Canopy Biosciences, a St. Louis-based multi-omic services company backed by Ampersand Capital Partners, has acquired Core Diagnostics, a California CLIA-certified biomarker analysis laboratory. The acquisition gives Canopy CLIA-certified laboratory capabilities to offer its multi-omic immune profiling services to clinical as well as preclinical and translational customers.